Wolverine Asset Management’s Adial Pharmaceuticals Warrant ADILW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-15,606
| Closed | -$88 | – | 2089 |
|
|
2023
Q2 | $88 | Hold |
15,606
| – | – | ﹤0.01% | 1756 |
|
|
2023
Q1 | $578 | Sell |
15,606
-2,400
| -13% | -$139 | ﹤0.01% | 1749 |
|
|
2022
Q4 | $450 | Hold |
18,006
| – | – | ﹤0.01% | 1999 |
|
|
2022
Q3 | $1K | Buy |
18,006
+10,511
| +140% | +$1.05K | ﹤0.01% | 2349 |
|
|
2022
Q2 | $2K | Buy |
7,495
+4,240
| +130% | +$1.64K | ﹤0.01% | 2251 |
|
|
2022
Q1 | $1K | Buy |
+3,255
| New | +$2.15K | ﹤0.01% | 2121 |
|
|
2021
Q4 | – | Sell |
-4,300
| Closed | -$3K | – | 2322 |
|
|
2021
Q3 | $3K | Sell |
4,300
-4,506
| -51% | -$3.72K | ﹤0.01% | 1896 |
|
|
2021
Q2 | $6K | Buy |
8,806
+4,302
| +96% | +$2.89K | ﹤0.01% | 2051 |
|
|
2021
Q1 | $2K | Buy |
+4,504
| New | +$2.99K | ﹤0.01% | 1966 |
|
|
2019
Q4 | – | Sell |
-627
| Closed | – | – | 1574 |
|
|
2019
Q3 | $0 | Sell |
627
-677
| -52% | -$162 | ﹤0.01% | 1682 |
|
|
2019
Q2 | $0 | Buy |
1,304
+1,104
| +552% | +$378 | ﹤0.01% | 1638 |
|
|
2019
Q1 | $0 | Buy |
+200
| New | +$146 | ﹤0.01% | 1781 |
|
Wolverine Asset Management's ADILW Position: Q3 2023 in Review
Wolverine Asset Management sold out of Adial Pharmaceuticals Warrant (ADILW) in Q3 2023, closing a stake of 15,606 shares — an estimated $88 sold.
Wolverine Asset Management first reported a position in ADILW in Q1 2019 and held it in 12 quarters. The position peaked at $6K in Q2 2021. 0 funds tracked by Wall St. Rank hold ADILW as of Q3 2023.
- Wolverine Asset Management reported no remaining Adial Pharmaceuticals Warrant position as of Q3 2023 after selling out during the quarter.
- Wolverine Asset Management sold 15,606 Adial Pharmaceuticals Warrant shares in Q3 2023, an estimated $88.
- Wolverine Asset Management first reported a position in Adial Pharmaceuticals Warrant in Q1 2019 and held it in 12 quarters.
- Wolverine Asset Management's Adial Pharmaceuticals Warrant position peaked at $6K in Q2 2021.
- 0 funds tracked by Wall St. Rank held Adial Pharmaceuticals Warrant as of Q3 2023.
Based on Wolverine Asset Management's 13F filing for Q3 2023, filed 13 Nov 2023.